
    
      -  Patients must have completed at least 5 years and not more than 7 years of continued
           treatment with tamoxifen (20 mg/day), while tamoxifen could have been discontinued up to
           6 months prior to study entry.

        -  A substudy (ATENA lipid substudy)is designed to evaluate changes in the patients' serum
           lipid profile during study treatment.
    
  